Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Hospitals

 

Sen brings break up smarts to Fresenius

Michael Sen, the new CEO of Fresenius SE, was previously hired back by Siemens to lead the break up IPO of Siemens Healthineers. So will Sen, currently the CEO of Fresenius’ infusion, transfusion and clinical nutrition subsidiary Kabi, be for revolution or continuity?
August 26, 2022

Netherlands to end free choice in health care

The Dutch government is seeking to end free choice within health care by removing the obligation on health insurers to reimburse care from any provider. The proposal is part of the cabinet’s plan to shake up the Netherland’s health care system, and will make it much harder for new entrants to compete with established providers. HBI chats with two market experts to find out more.
August 19, 2022

KKR exits Max Healthcare

US private equity player KKR has solid its entire stake in India-based hospital chain Max Healthcare, marking its exit from the group, for around Rs9,200 crore. The deal marks its largest exit from an Indian firm, and is the largest single block deal done by any PE firm in India.
August 19, 2022

Lusiadas deal still on as seller carries cost of muti-million fine

The planned acquisition of Lusiadas Saude, Portugal's third largest hospital group, by France's third largest hospital group Vivalto Sante, will not be impacted by the €34.2m fine that has been handed to Lusiadas by Portugal's competition authority.
August 18, 2022

Bupa and Ramsay Australia resolve tariff tiff

Insurer Bupa and the Australian branch of multinational hospital chain Ramsay have managed to reach an in-principle agreement over price increases, ensuring Bupa-insured Australians will be able to continue to receive care in Ramsay hospitals for the next three years.
August 18, 2022

Mediclinic accepts £3.7bn bid

The board of Mediclinic, the South Africa-based multinational hospital giant, have announced they have agreed acquisition terms with the consortium comprised of Remgro, the investment vehicle of the billionaire Rupert family and a long-time Mediclinic shareholder, and the Mediterranean Shipping Company (MSC). They have recommended these terms to shareholders.
August 5, 2022

Fresenius: “We’re not selling”

Germany-based healthcare conglomerate Fresenius tells HBI it isn't currently looking to carve off parts of its business for sale, and despite mixed H1 results it sees plenty of opportunities for growth.
August 5, 2022
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us